Exenatide and sitagliptin are not associated with increased risk of acute renal failure: a retrospective claims analysis

Abstract

Our study revealed an increased incidence of ARF in diabetic versus non-diabetic patients but no association between use of exenatide or sitagliptin and ARF. Because of the limitations of this observational analysis, we cannot exclude the possibility of a very small increased risk.